Hovnik et al. [35] concluded that carriers of both the GSTM1 null and GSTT1 null genotypes, and a consequent complete lack of GSTM1 and GSTT1 enzyme activity, were not at higher risk of developing macroangiopathic complications in type 1 diabetes. The gene discussed is GSTM1; the disease is type 1 diabetes mellitus.